Researchers have confirmed a peptide itself derived from thrombin-processed C2ORF40 could induce the myeloid cell accumulation and activate macrophages to exert the proinflammatory function in glioma [38], [39]. The gene discussed is ECRG4; the disease is central nervous system cancer.